Eikon Therapeutics is a biopharmaceutical company focused on advancing breakthrough therapeutics through the purposeful integration of science and engineering. It emphasizes innovative approaches at the intersection of biology and engineering to accelerate drug discovery and development. The company operates with a footprint in the United States, including locations in Millbrae, California, New York, New York, and Jersey City, New Jersey, reflecting a multi-site research and development presence.